Hepatitis C OnlineLogo
Section Navigation
Common TitleSURVEYOR-I and SURVEYOR-II
Official Title Glecaprevir and Pibrentasvir Yield High Response Rates in Patients with HCV Genotype 1-6 without Cirrhosis.
Phase Phase II
ClinicalTrials.gov NCT02243280
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir

Tradename:MavyretOther Names:GLE-PIBClass:FDA-Approved
Funding
IndustryAbbVie

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.